20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with adenosine-5'-(n-ethylcarboxamide) in 1 studies
Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (adenosine-5'-(n-ethylcarboxamide)) | Trials (adenosine-5'-(n-ethylcarboxamide)) | Recent Studies (post-2010) (adenosine-5'-(n-ethylcarboxamide)) |
---|---|---|---|---|---|
640 | 13 | 233 | 1,333 | 4 | 133 |
Protein | Taxonomy | 20-hydroxy-5,8,11,14-eicosatetraenoic acid (IC50) | adenosine-5'-(n-ethylcarboxamide) (IC50) |
---|---|---|---|
Adenosine receptor A3 | Homo sapiens (human) | 0.0097 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.037 | |
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.4498 | |
Adenosine receptor A2a | Homo sapiens (human) | 0.0336 | |
Adenosine receptor A2b | Rattus norvegicus (Norway rat) | 0.0175 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0007 | |
Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.0513 | |
Adenosine receptor A1 | Gallus gallus (chicken) | 0.017 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boegehold, MA; Falck, JR; Mustafa, SJ; Nayeem, MA; Ponnoth, DS; Zeldin, DC | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and adenosine-5'-(n-ethylcarboxamide)
Article | Year |
---|---|
High-salt diet enhances mouse aortic relaxation through adenosine A2A receptor via CYP epoxygenases.
Topics: Acetylcholine; Adenosine; Adenosine-5'-(N-ethylcarboxamide); Animals; Antihypertensive Agents; Aorta, Abdominal; Aorta, Thoracic; Blotting, Western; Cytochrome P-450 CYP2J2; Cytochrome P-450 CYP4A; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Enzyme Inhibitors; Hydroxyeicosatetraenoic Acids; Mice; Mice, Inbred C57BL; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type III; Phenethylamines; Receptor, Adenosine A2A; Sodium, Dietary; Vasodilator Agents | 2009 |